Ashurst advised Varian Medical Systems, Inc. ("Varian") on all legal aspects in connection with the takeover of 73.5 per cent of the share capital of the listed corporation MeVis Medical Solutions AG ("MeVis"). The acquisition was carried out by means of a voluntary public takeover offer made by VMS Deutschland Holdings GmbH, an indirect German subsidiary of Varian.

The Ashurst team was led by partner Dr Benedikt von Schorlemer and counsel Martina Rothe, supported by associate Dr Angela Loff (all Corporate). The employment law team led by partner Dr Andreas Mauroschat, counsel Dr Maximilian Boemke (Public Law) as well as associates Dr Ian M. Maywald and Marcel Goroll (Corporate, all Frankfurt) assisted in the due diligence.

Ashurst's longstanding client, Varian Medical Systems, Inc., with revenues of $3 billion in 2014, is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions. The company, based in Palo Alto, California, employs approximately 6,800 people located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.

MeVis, Bremen, provides computer support for image-based medical diagnosis and therapy.